Agnieszka Morgenroth

Albert Einstein Allee 23
Ulm, BW 89081, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

IDH-genotype-linked kinase rewiring accompanies enhanced therapeutic response to dual-drug ferritin nanocages in high-grade glioma.

IDH-genotype-linked kinase rewiring accompanies enhanced therapeutic response to dual-drug ferritin nanocages in high-grade glioma.

Journal: Materials today. Bio

Published: May 13, 2026

Theranostic π Electron-Stabilized Polymeric Micelles for PET Imaging-Guided Drug Delivery to Tumors.

Theranostic π Electron-Stabilized Polymeric Micelles for PET Imaging-Guided Drug Delivery to Tumors.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: January 27, 2026

Bimodal nanobody agents for cancer imaging and potential intraoperative guidance: a systematic review.

Bimodal nanobody agents for cancer imaging and potential intraoperative guidance: a systematic review.

Journal: Journal of nanobiotechnology

Published: November 11, 2025

Nectin-4-Targeted Radiotheranostics for Personalized Cancer Therapy: A Systematic Review.

Nectin-4-Targeted Radiotheranostics for Personalized Cancer Therapy: A Systematic Review.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: September 16, 2025

Androgen receptor blockade and its effect on PSMA-localization in prostate cancer: Implications for radioligand therapy.

Androgen receptor blockade and its effect on PSMA-localization in prostate cancer: Implications for radioligand therapy.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: August 05, 2025

Theranostic application of radiolabeled HER2-targeting single-domain antibodies (RAD202) in preclinical setting.

Theranostic application of radiolabeled HER2-targeting single-domain antibodies (RAD202) in preclinical setting.

Journal: Scientific reports

Published: July 24, 2025

Combining PSMA-Targeted Radiopharmaceutical Therapy with Immunotherapy.

Combining PSMA-Targeted Radiopharmaceutical Therapy with Immunotherapy.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: May 06, 2025

Advancements in non-invasive visualization of the immune checkpoint TIGIT: a systematic review.

Advancements in non-invasive visualization of the immune checkpoint TIGIT: a systematic review.

Journal: European journal of nuclear medicine and molecular imaging

Published: March 04, 2025

Mechanism of Action and Interaction of Garlic Extract and Established Therapeutics in Prostate Cancer.

Mechanism of Action and Interaction of Garlic Extract and Established Therapeutics in Prostate Cancer.

Journal: International journal of molecular sciences

Published: January 28, 2025

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-labelled Nano Molecules.

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-labelled Nano Molecules.

Journal: Journal of visualized experiments : JoVE

Published: October 21, 2024

Correction to: HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging.

Correction to: HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging.

Journal: European journal of nuclear medicine and molecular imaging

Published: June 20, 2024

The prostate-specific membrane antigen holds potential as a vascular target for endogenous radiotherapy with [177Lu]Lu-PSMA-I&T for triple-negative breast cancer.

The prostate-specific membrane antigen holds potential as a vascular target for endogenous radiotherapy with [177Lu]Lu-PSMA-I&T for triple-negative breast cancer.

Journal: Breast cancer research : BCR

Published: November 30, 2023

Showing 1-12 of 47

Last Updated: 09/26/2026